View DividendThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsFutureCoreLtd マネジメントマネジメント 基準チェック /04現在、CEO に関する十分な情報がありません。主要情報BaeSeong Kim最高経営責任者n/a報酬総額CEO給与比率n/aCEO在任期間1.2yrsCEOの所有権n/a経営陣の平均在職期間データなし取締役会の平均在任期間1.2yrs経営陣の近況Board Change • Nov 18High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. Independent Outside Director SeungKwan Choi is the most experienced director on the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Mar 18FutureCore Co.,Ltd., Annual General Meeting, Mar 31, 2025FutureCore Co.,Ltd., Annual General Meeting, Mar 31, 2025, at 09:00 Tokyo Standard Time. Location: auditorium, 13, sinwon-ro 250beon-gil, yeongtong-gu, gyeonggi-do, suwon South KoreaBoard Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Outside Director Hyuk-Jae Lee was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Outside Director Hyuk-Jae Lee was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.すべての更新を表示Recent updates分析記事 • Nov 24FutureCoreLtd (KOSDAQ:151910) Shareholders Will Want The ROCE Trajectory To ContinueFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Board Change • Nov 18High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. Independent Outside Director SeungKwan Choi is the most experienced director on the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Jul 17An undisclosed buyer agreed to acquire 99.79% stake in GVBT Union No. 4 from FutureCore Co.,Ltd. (KOSDAQ:A151910) for KRW 3.6 billion.An undisclosed buyer agreed to acquire 99.79% stake in GVBT Union No. 4 from FutureCore Co.,Ltd. (KOSDAQ:A151910) for KRW 3.6 billion on April 17, 2025. A cash consideration of KRW 3.6 billion will be paid by the buyer. The expected completion of the transaction is September 16, 2025.お知らせ • Mar 18FutureCore Co.,Ltd., Annual General Meeting, Mar 31, 2025FutureCore Co.,Ltd., Annual General Meeting, Mar 31, 2025, at 09:00 Tokyo Standard Time. Location: auditorium, 13, sinwon-ro 250beon-gil, yeongtong-gu, gyeonggi-do, suwon South KoreaNew Risk • Mar 20New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 6.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 7.3% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (6.3% increase in shares outstanding). Market cap is less than US$100m (₩120.6b market cap, or US$90.2m).Reported Earnings • Mar 15Full year 2023 earnings released: ₩43.00 loss per share (vs ₩91.00 loss in FY 2022)Full year 2023 results: ₩43.00 loss per share (improved from ₩91.00 loss in FY 2022). Revenue: ₩48.3b (down 5.0% from FY 2022). Net loss: ₩7.66b (loss narrowed 52% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 57% per year, which means it is performing significantly worse than earnings.分析記事 • Feb 27Subdued Growth No Barrier To SBW Life Sciences Co.,Ltd. (KOSDAQ:151910) With Shares Advancing 51%SBW Life Sciences Co.,Ltd. ( KOSDAQ:151910 ) shareholders would be excited to see that the share price has had a great...New Risk • Feb 16New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 7.0% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩77.6b market cap, or US$58.3m).New Risk • Dec 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 7.0% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Market cap is less than US$100m (₩76.2b market cap, or US$57.9m).New Risk • Jun 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 7.6% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (₩93.3b market cap, or US$71.3m).Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Outside Director Hyuk-Jae Lee was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Jul 19SBW Life Sciences Co.,Ltd. announced that it has received KRW 17.6 billion in funding from IokCompany Co., Ltd.On July 18, 2022, SBW Life Sciences Co.,Ltd. closed the transaction.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Outside Director Hyuk-Jae Lee was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Apr 07Nanos Co., Ltd. announced that it has received KRW 30 billion in fundingOn April 5, 2021, Nanos Co., Ltd. (KOSDAQ:A151910) closed the transaction.Is New 90 Day High Low • Feb 20New 90-day high: ₩7,070The company is up 105% from its price of ₩3,445 on 20 November 2020. The South Korean market is up 19% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 39% over the same period.お知らせ • Feb 10Nanos Co., Ltd. announced that it expects to receive KRW 30 billion in fundingNanos Co., Ltd. (KOSDAQ:A151910) announced a private placement of round 5 Unregistered coupon nonguaranteed private convertible bond for gross proceeds of KRW 30,000,000,000 on February 9, 2021. The transaction will include participation from DB W Fund 1. The bond carry 4% coupon nominal rate, 6% maturity rate and will mature on April 5, 2026. The bonds can be 100% converted into 7,447,864 common shares at a conversion price of KRW 4,028 per share for 4.77% stakes. The conversion period is from April 5, 2022 to March 5, 2026. The transaction has been approved by the board of directors of the company. The securities issued in the transaction are subject to one year lock up period. The subscription date is February 15, 2021 and the payment date is April 5, 2021.Is New 90 Day High Low • Feb 03New 90-day high: ₩4,150The company is up 21% from its price of ₩3,425 on 05 November 2020. The South Korean market is up 28% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 44% over the same period.Is New 90 Day High Low • Jan 17New 90-day high: ₩3,700The company is up 1.0% from its price of ₩3,675 on 19 October 2020. The South Korean market is up 30% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 44% over the same period.Is New 90 Day High Low • Dec 15New 90-day low: ₩3,300The company is down 20% from its price of ₩4,100 on 16 September 2020. The South Korean market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 9.0% over the same period.Is New 90 Day High Low • Nov 11New 90-day low: ₩3,305The company is down 12% from its price of ₩3,740 on 13 August 2020. The South Korean market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 3.0% over the same period.Is New 90 Day High Low • Oct 22New 90-day low: ₩3,600The company is down 17% from its price of ₩4,360 on 24 July 2020. The South Korean market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 5.0% over the same period.お知らせ • Jul 17+ 1 more updateNanos Co., Ltd. announced that it expects to receive KRW 3 billion in funding from Mirae Industry CO.,LTDNanos Co., Ltd. (KOSDAQ:A151910) announced a private placement of round four non-guaranteed private equity convertible bonds for gross proceeds of KRW 3,000,000,000 on July 13, 2020. The transaction will include participation from Mirae Industry CO.,LTD for KRW 3,000,000,000. The bond carry 2 percent coupon nominal rate, 2% maturity rate and will mature on July 14, 2023. The bonds can be 100% converted into 813,890 common shares at a conversion price of KRW 3,686 per share. The conversion period is from July 14, 2021 to June 14, 2023. The transaction has been approved by the board of directors of the company. The subscription date is July 14, 2020 and the payment date is July 14, 2020.CEOBaeSeong Kim (48 yo)1.2yrs在職期間Mr. BaeSeong Kim serves as CEO & Director of FutureCore Co.,Ltd. since September 5 , 2024.取締役名称ポジション在職期間報酬所有権BaeSeong KimCEO & Director1.2yrsデータなしデータなしJeongSeon SongIndependent Outside Director1.2yrsデータなしデータなしYongGeon JoInside Director1.2yrsデータなしデータなしHwanJun YunInside Director1.2yrsデータなしデータなしJongSeong WonIndependent Outside Director1.2yrsデータなしデータなしHyeonJu LimIndependent Outside Director1.2yrsデータなしデータなしSeungKwan ChoiIndependent Outside Director1.2yrsデータなしデータなしもっと見る1.2yrs平均在職期間50yo平均年齢経験豊富なボード: A151910の 取締役会 は 経験豊富 ではない ( 1.2年の平均在任期間) ため、新しい取締役会が必要であると考えられます。View Ownership企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2025/11/26 18:37終値2025/11/25 00:00収益2025/06/30年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋FutureCore Co.,Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関Jun-Ho ByunEugene Investment & Securities Co Ltd.JooYoung LeeShinhan Investment Corp.Hyung Wou ParkSK Securities Co., Ltd.
Board Change • Nov 18High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. Independent Outside Director SeungKwan Choi is the most experienced director on the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Mar 18FutureCore Co.,Ltd., Annual General Meeting, Mar 31, 2025FutureCore Co.,Ltd., Annual General Meeting, Mar 31, 2025, at 09:00 Tokyo Standard Time. Location: auditorium, 13, sinwon-ro 250beon-gil, yeongtong-gu, gyeonggi-do, suwon South Korea
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Outside Director Hyuk-Jae Lee was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Outside Director Hyuk-Jae Lee was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
分析記事 • Nov 24FutureCoreLtd (KOSDAQ:151910) Shareholders Will Want The ROCE Trajectory To ContinueFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Board Change • Nov 18High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. Independent Outside Director SeungKwan Choi is the most experienced director on the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Jul 17An undisclosed buyer agreed to acquire 99.79% stake in GVBT Union No. 4 from FutureCore Co.,Ltd. (KOSDAQ:A151910) for KRW 3.6 billion.An undisclosed buyer agreed to acquire 99.79% stake in GVBT Union No. 4 from FutureCore Co.,Ltd. (KOSDAQ:A151910) for KRW 3.6 billion on April 17, 2025. A cash consideration of KRW 3.6 billion will be paid by the buyer. The expected completion of the transaction is September 16, 2025.
お知らせ • Mar 18FutureCore Co.,Ltd., Annual General Meeting, Mar 31, 2025FutureCore Co.,Ltd., Annual General Meeting, Mar 31, 2025, at 09:00 Tokyo Standard Time. Location: auditorium, 13, sinwon-ro 250beon-gil, yeongtong-gu, gyeonggi-do, suwon South Korea
New Risk • Mar 20New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 6.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 7.3% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (6.3% increase in shares outstanding). Market cap is less than US$100m (₩120.6b market cap, or US$90.2m).
Reported Earnings • Mar 15Full year 2023 earnings released: ₩43.00 loss per share (vs ₩91.00 loss in FY 2022)Full year 2023 results: ₩43.00 loss per share (improved from ₩91.00 loss in FY 2022). Revenue: ₩48.3b (down 5.0% from FY 2022). Net loss: ₩7.66b (loss narrowed 52% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 57% per year, which means it is performing significantly worse than earnings.
分析記事 • Feb 27Subdued Growth No Barrier To SBW Life Sciences Co.,Ltd. (KOSDAQ:151910) With Shares Advancing 51%SBW Life Sciences Co.,Ltd. ( KOSDAQ:151910 ) shareholders would be excited to see that the share price has had a great...
New Risk • Feb 16New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 7.0% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩77.6b market cap, or US$58.3m).
New Risk • Dec 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 7.0% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Market cap is less than US$100m (₩76.2b market cap, or US$57.9m).
New Risk • Jun 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 7.6% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (₩93.3b market cap, or US$71.3m).
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Outside Director Hyuk-Jae Lee was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Jul 19SBW Life Sciences Co.,Ltd. announced that it has received KRW 17.6 billion in funding from IokCompany Co., Ltd.On July 18, 2022, SBW Life Sciences Co.,Ltd. closed the transaction.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Outside Director Hyuk-Jae Lee was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Apr 07Nanos Co., Ltd. announced that it has received KRW 30 billion in fundingOn April 5, 2021, Nanos Co., Ltd. (KOSDAQ:A151910) closed the transaction.
Is New 90 Day High Low • Feb 20New 90-day high: ₩7,070The company is up 105% from its price of ₩3,445 on 20 November 2020. The South Korean market is up 19% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 39% over the same period.
お知らせ • Feb 10Nanos Co., Ltd. announced that it expects to receive KRW 30 billion in fundingNanos Co., Ltd. (KOSDAQ:A151910) announced a private placement of round 5 Unregistered coupon nonguaranteed private convertible bond for gross proceeds of KRW 30,000,000,000 on February 9, 2021. The transaction will include participation from DB W Fund 1. The bond carry 4% coupon nominal rate, 6% maturity rate and will mature on April 5, 2026. The bonds can be 100% converted into 7,447,864 common shares at a conversion price of KRW 4,028 per share for 4.77% stakes. The conversion period is from April 5, 2022 to March 5, 2026. The transaction has been approved by the board of directors of the company. The securities issued in the transaction are subject to one year lock up period. The subscription date is February 15, 2021 and the payment date is April 5, 2021.
Is New 90 Day High Low • Feb 03New 90-day high: ₩4,150The company is up 21% from its price of ₩3,425 on 05 November 2020. The South Korean market is up 28% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 44% over the same period.
Is New 90 Day High Low • Jan 17New 90-day high: ₩3,700The company is up 1.0% from its price of ₩3,675 on 19 October 2020. The South Korean market is up 30% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 44% over the same period.
Is New 90 Day High Low • Dec 15New 90-day low: ₩3,300The company is down 20% from its price of ₩4,100 on 16 September 2020. The South Korean market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 9.0% over the same period.
Is New 90 Day High Low • Nov 11New 90-day low: ₩3,305The company is down 12% from its price of ₩3,740 on 13 August 2020. The South Korean market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 3.0% over the same period.
Is New 90 Day High Low • Oct 22New 90-day low: ₩3,600The company is down 17% from its price of ₩4,360 on 24 July 2020. The South Korean market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 5.0% over the same period.
お知らせ • Jul 17+ 1 more updateNanos Co., Ltd. announced that it expects to receive KRW 3 billion in funding from Mirae Industry CO.,LTDNanos Co., Ltd. (KOSDAQ:A151910) announced a private placement of round four non-guaranteed private equity convertible bonds for gross proceeds of KRW 3,000,000,000 on July 13, 2020. The transaction will include participation from Mirae Industry CO.,LTD for KRW 3,000,000,000. The bond carry 2 percent coupon nominal rate, 2% maturity rate and will mature on July 14, 2023. The bonds can be 100% converted into 813,890 common shares at a conversion price of KRW 3,686 per share. The conversion period is from July 14, 2021 to June 14, 2023. The transaction has been approved by the board of directors of the company. The subscription date is July 14, 2020 and the payment date is July 14, 2020.